Carcinoembryonic antigen (CEA) and mesothelin (MSLN) were highly expressed in pancreatic cancer, and dual-receptor CAR T cells targeting both antigens were found to target tumor sites precisely and reduce tumor load in pancreatic cancer mouse models (Figure 1C) (49). This evidence concerns the gene CEACAM5 and pancreatic neoplasm.